Picture of L&C Bio Co logo

290650 L&C Bio Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Annual cashflow statement for L&C Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line8,45412,14915,5805,69248,531
Depreciation
Amortisation
Non-Cash Items1,491-3,050-1,0946,076-38,870
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-4,600-3,267-6,481-22,351-27,449
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities6,4317,41910,907-6,076-12,133
Capital Expenditures-2,009-3,055-11,428-37,703-24,984
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-13,8053,878-9,060-45,92949,618
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-15,814824-20,488-83,63324,634
Financing Cash Flow Items42515.32,55453.6-70
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5271,2614,69778,928-4,155
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-8,8569,500-4,884-10,7908,357